These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33095099)

  • 21. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Serrano D; Nicholson RA; Buse DC; Runken MC; Reed ML
    Headache; 2013; 53(10):1548-63. PubMed ID: 23992516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
    Runken MC; Goodwin B; Shah M; Eaddy M; D'Souza A; Bowers B; Bell CF
    Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.
    Frisk P; Sporrong SK; Ljunggren G; Wettermark B; von Euler M
    Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable].
    Perearnau P; Vuillemet F; Schick J; Weill G
    Rev Neurol (Paris); 2006 Mar; 162(3):347-57. PubMed ID: 16585890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac risk factors and the use of triptans: a survey study.
    Young WB; Mannix L; Adelman JU; Shechter AL
    Headache; 2000; 40(7):587-91. PubMed ID: 10940098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptans for Acute Migraine Headache: Current Experience With Triptan Use and Prescription Habits in a Tertiary Care Headache Outpatient Clinic: An Observational Study.
    Fischer M; Frank F; Wille G; Klien S; Lackner P; Broessner G
    Headache; 2016 Jun; 56(6):952-60. PubMed ID: 27091593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptan education and improving knowledge for optimal migraine treatment: an observational study.
    Baron EP; Markowitz SY; Lettich A; Hastriter E; Lovell B; Kalidas K; Dodick DW; Schwedt TJ;
    Headache; 2014 Apr; 54(4):686-97. PubMed ID: 24520930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usage of triptans among migraine patients: an audit in nine GP practices.
    Williams D; Cahill T; Dowson A; Fearon H; Lipscombe S; O'Sullivan E; Rees T; Strang C; Valori A; Watson D
    Curr Med Res Opin; 2002; 18(1):1-9. PubMed ID: 11999139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study.
    Li H; Vincent M; Zhang X; Dennehy EB; Goodloe R; Aurora SK; Smith TR
    Pain Ther; 2020 Dec; 9(2):499-509. PubMed ID: 32328974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M; Ravasio R
    Clin Drug Investig; 2009; 29(11):693-702. PubMed ID: 19813772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) Study.
    Takeshima T; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Matsumori Y; Hirata K
    Adv Ther; 2022 Nov; 39(11):5176-5190. PubMed ID: 36089637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry.
    Ruscheweyh R; Gossrau G; Dresler T; Freilinger T; Förderreuther S; Gaul C; Kraya T; Neeb L; Ruschil V; Straube A; Scheidt J; Jürgens TP
    J Headache Pain; 2023 Oct; 24(1):135. PubMed ID: 37817093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological interventions for acute attacks of vestibular migraine.
    Webster KE; Dor A; Galbraith K; Haj Kassem L; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD015322. PubMed ID: 37042545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure.
    Sacco S; Lampl C; Amin FM; Braschinsky M; Deligianni C; Uludüz D; Versijpt J; Ducros A; Gil-Gouveia R; Katsarava Z; Martelletti P; Ornello R; Raffaelli B; Boucherie DM; Pozo-Rosich P; Sanchez-Del-Rio M; Sinclair A; Maassen van den Brink A; Reuter U
    J Headache Pain; 2022 Oct; 23(1):133. PubMed ID: 36224519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptans Use for Migraine Headache among Nonelderly Adults with Cardiovascular Risk.
    Alwhaibi M; Deb A; Sambamoorthi U
    Pain Res Treat; 2016; 2016():8538101. PubMed ID: 27630773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice.
    Hall GC; Brown MM; Mo J; MacRae KD
    Neurology; 2004 Feb; 62(4):563-8. PubMed ID: 14981171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migraine burden and costs in France: a nationwide claims database analysis of triptan users.
    Donnet A; Emery C; Aly S; Allaf B; Cayre F; Mahieu N; Gourmelen J; Levy P; Fagnani F
    J Med Econ; 2019 Jul; 22(7):616-624. PubMed ID: 30836035
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiology, Demographics, Triptan Contraindications, and Prescription Patterns of Patients with Migraine: A German Claims Database Study.
    Gendolla A; Rauer N; Kraemer S; Schwerdtner I; Straube A
    Neurol Ther; 2022 Mar; 11(1):167-183. PubMed ID: 34837636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.